Dyno Therapeutics logo

Dyno Therapeutics

We build AI-powered gene therapies.

95 employees · est. 2018 · Watertown, United States

VS
SynHelix logo

SynHelix

Demand for synthetic DNA is growing rapidly in biotech industry, and SynHelix aims to meet supply needs.

11-50 employees · est. 2019 · Evry, France

Dyno Therapeutics is the older company (2018 vs 2019); Dyno Therapeutics is the larger of the two.

Side-by-Side Comparison

Dyno Therapeutics SynHelix
Founded
2018 older 2019
Headquarters
Watertown, United States Evry, France
Employees
95 larger 11-50
Industry
Biotechnology, Pharmaceutical Biotechnology
Funding Stage
Series A Not tracked yet
Total Funding
$109.00M Not tracked yet
Funding Rounds
3 Not tracked yet
Services
Development of high-performance genetic technologies, AI-driven solutions for genetic advancements, Collaborative partnerships in genetic research Not tracked yet
Target Customers
Patients requiring genetic intervention, Healthcare providers, Pharmaceutical companies seeking genetic solutions Not tracked yet
Taxonomy
AI-powered Gene Therapy, High-Performance Genetic Technologies, Machine Learning In Gene Therapy, Gene Vector Design, Adeno-Associated Virus (AAV) Engineering, Cell-Targeting Capsid Proteins, Synthetic Biology, Next-Generation Sequencing (NGS), In Vivo Experimentation, Data Science In Genomics, Genome Editing, Protein Engineering, Biotechnology Innovations, AI In Healthcare, Therapeutic Development Synthetic Biology, DNA Constructs, Molecular Biology, Gene Synthesis, Gene Therapy, Biotherapeutics, Protein Engineering, Recombinant Proteins, Biochemistry, Enzymology, Computational Biology, Cell Therapy, Nanotechnology
Website
dynotx.com synhelix.com
Dyno Therapeutics logo

About Dyno Therapeutics

Dyno Therapeutics is an innovative player in the biotechnology and pharmaceutical industries, pioneering the development of AI-powered gene therapies. Founded in 2018, the company is committed to building high-performance genetic technologies designed to transform patient lives. Headquartered in the...

SynHelix logo

About SynHelix

SynHelix is a biotech startup based in France, founded in 2019, that has identified a significant market opportunity in the rapidly growing demand for synthetic DNA in fields such as synthetic biology, gene therapy, and diagnostics. The company aims to address the current supply bottleneck faced by...

We will tell you when either one moves

BounceWatch watches Dyno Therapeutics and SynHelix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Dyno Therapeutics and SynHelix — by email.

Frequently Asked Questions

Dyno Therapeutics — We build AI-powered gene therapies.. SynHelix — Demand for synthetic DNA is growing rapidly in biotech industry, and SynHelix aims to meet supply needs.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Dyno Therapeutics has raised $109.00M while SynHelix has raised undisclosed funding.
Dyno Therapeutics and SynHelix operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Dyno Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Dyno Therapeutics on 15 Jun 2026, and SynHelix on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy